Vaginal progesterone delivers the hormone progesterone directly to the uterus, where it thickens and stabilizes the uterine lining to support pregnancy. It’s prescribed in three main situations: during fertility treatments like IVF, to reduce the risk of preterm birth in women with a short cervix, and as part of hormone replacement therapy during menopause. The vaginal route is favored because it concentrates the hormone where it’s needed most, in the uterine tissue, while keeping levels in the rest of the body relatively low.
How It Works in the Uterus
Progesterone is the hormone that transforms the uterine lining from a thin, inactive state into a thick, nutrient-rich environment ready to receive an embryo. This transformation, called decidualization, is what makes the lining “sticky” enough for a fertilized egg to implant. Without adequate progesterone, the lining can’t support implantation, and pregnancy either won’t begin or won’t survive its earliest days.
Beyond preparing the lining, progesterone also quiets uterine muscle contractions and modulates the immune system so the body tolerates a developing pregnancy rather than rejecting it. These effects are essential not just at the moment of implantation but throughout the first trimester, until the placenta takes over hormone production.
Why the Vaginal Route Specifically
When progesterone is inserted vaginally, it’s absorbed through the vaginal walls and travels directly to the uterus before entering the general bloodstream. Researchers call this the “first uterine pass effect.” The result is that progesterone concentrations inside the uterine tissue end up significantly higher than what shows up in a blood test, which is the opposite of what happens with an oral capsule.
Oral progesterone passes through the liver first, which breaks down a large portion of it before it ever reaches the uterus. While overall absorption between oral and vaginal forms is similar, the distribution is different. Vaginal delivery puts the hormone where it matters most for reproductive purposes. Blood levels after vaginal use peak within about 8 hours and can range widely depending on the dose and formulation, but the key advantage is the high local concentration in uterine tissue.
Supporting Embryo Implantation During IVF
Vaginal progesterone is a cornerstone of IVF treatment. During a typical IVF cycle, the medications used to stimulate egg production disrupt the body’s natural progesterone output. After eggs are retrieved and embryos are transferred, the uterine lining needs progesterone supplementation to stay receptive. Without it, the lining may not be prepared enough for the embryo to implant successfully.
In frozen embryo transfer cycles, this is even more critical. The body hasn’t gone through ovulation at all, so there’s no natural progesterone surge. Vaginal gels or suppositories fill that gap, creating the hormonal environment the embryo needs. Treatment typically starts a few days before embryo transfer and continues into early pregnancy. How long you stay on it varies by clinic: some doctors stop supplementation as early as a positive pregnancy test, while others continue until 9 to 12 weeks of gestation, when the placenta reliably produces its own progesterone. Many clinicians err on the side of continuing longer to minimize miscarriage risk.
Common vaginal progesterone products used in fertility treatment include gels applied once or twice daily and small suppositories or inserts used two to three times per day. Your fertility clinic will choose the form and schedule based on your specific cycle type.
Preventing Preterm Birth
For pregnant women found to have a short cervix on ultrasound, vaginal progesterone can substantially lower the chance of delivering too early. Most guidelines recommend starting treatment when the cervix measures less than 25 millimeters during a routine mid-pregnancy ultrasound, typically performed between 18 and 24 weeks. Some guidelines use a stricter cutoff of 20 or even 15 millimeters, but 25 millimeters is the most widely used threshold.
The benefit can be dramatic. In one study of women with a short cervix identified before 24 weeks, the rate of delivery before 32 weeks was 2.8% in the group receiving vaginal progesterone compared to 33.3% in the group that did not. This matters enormously because babies born before 32 weeks face serious risks including breathing problems, feeding difficulties, and long-term developmental concerns. The progesterone works by keeping the cervix stable and the uterine muscle relaxed, buying critical extra weeks of development.
This use applies specifically to singleton pregnancies. The evidence for twins or higher-order multiples is less clear, and recommendations differ across medical organizations.
Protecting the Uterine Lining During Menopause
Women going through menopause who take estrogen therapy to manage symptoms like hot flashes and vaginal dryness need progesterone as well, unless they’ve had a hysterectomy. Estrogen on its own stimulates the uterine lining to grow, and over time, that unchecked growth can lead to abnormal thickening or even uterine cancer. Progesterone counteracts this by signaling the lining to mature and shed rather than continuing to build up.
Vaginal micronized progesterone is one option for this protective role. In studies comparing it to other forms, vaginally delivered progesterone tended to produce a functional, secretory lining rather than the thinned-out, atrophic lining seen with some synthetic alternatives. For women who prefer to maintain a monthly cycle while on hormone therapy, vaginal progesterone used cyclically (typically 12 days per month) offers an effective approach. It also appeals to women who want to avoid the stronger systemic effects of oral synthetic progestins.
Common Side Effects
Because vaginal progesterone keeps most of the hormone concentrated locally, systemic side effects tend to be milder than with oral forms. That said, some women do experience headaches, breast tenderness, nausea, bloating, constipation, and drowsiness. Mood changes, including irritability or feeling emotionally flat, are also reported.
Local side effects are more specific to the vaginal route. You may notice increased vaginal discharge, which is partly the medication residue and partly increased cervical mucus. Some women experience mild irritation or a gritty sensation depending on the formulation. These local effects are generally manageable and tend to be less bothersome than the sleepiness and dizziness that oral progesterone commonly causes, since oral forms produce higher blood levels of progesterone’s sedating byproducts as the hormone passes through the liver.
If you’re using vaginal progesterone during early pregnancy, it’s worth knowing that many of the side effects overlap with normal pregnancy symptoms, which can make it hard to tell what’s causing what. Breast tenderness, fatigue, and nausea are all par for the course in the first trimester regardless of supplementation.